Explore News By Topic
05/06/2019
Gene mutation discovery linked to very poor survival in prostate cancer patients
Original Press Release Issued by: ICR (The Institute of Cancer Research) Scientists have identified a gene mutation in the tumours of men with prostate cancer that is linked to very poor survival – and which could be used to pick out patients for especially intensive treatment. Men with mutations in... Read More
03/28/2019
Researchers Discover How a Gene Deletion Contributes to Prostate Cancer Growth
Original Press Release Issued by: Weill Cornell Medicine The deletion of a gene that normally promotes healthy cell division in the prostate encourages the growth of cancer in the gland, according to a new study by Weill Cornell Medicine investigators. The findings, published March 28 in Cancer Cell, suggest that... Read More
03/20/2019
CURE Media Group Adds the Prostate Cancer Foundation to Its Strategic Alliance Partnership Program
CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group, which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates, research and education, has added the Prostate Cancer Foundation (PCF) to its Strategic Alliance Partnership (SAP) program. “PCF works hard to fund and accelerate research for... Read More
02/11/2019
Study finds upsurge in ‘active surveillance’ for low-risk prostate cancer
Original Press Release Issued by: Dana-Farber Cancer Institute Many men with low-risk prostate cancer who most likely previously would have undergone immediate surgery or radiation are now adopting a more conservative “active surveillance” strategy, according to an analysis of a new federal database by scientists from Dana-Farber Cancer Institute. The use... Read More
02/07/2019
Atlanta Hawks, Prostate Cancer Foundation Team Up To Fight Prostate Cancer
ATLANTA – The Atlanta Hawks and Prostate Cancer Foundation (PCF) have joined together to launch a first-of-its-kind multi-pronged program with the goal of slamming prostate cancer. Led by Hawks Vice Chair of the Board and Naismith Memorial Basketball Hall of Famer Grant Hill and his father, NFL Legend Calvin Hill, the Hawks are... Read More
01/31/2019
Fuego Box Turns Up The Heat On Prostate Cancer With The Choco Challenge™
LOS ANGELES - JANUARY 31, 2019 As Valentine’s Day approaches, spice up your life while supporting the fight against prostate cancer. Fuego Box, purveyors of small-batch/craft hot sauces delivered to your door monthly, is teaming up with the Prostate Cancer Foundation (PCF) on The Choco Challenge™, the world’s spiciest mini chocolate bar. People... Read More
12/18/2018
Prostate Cancer Scoring Method May Underestimate Mortality Risk in Black Men
Original Press Release Issued by: Dana-Farber Cancer Institute Black men diagnosed with prostate cancer classified as low risk may actually have a more aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests. This... Read More
11/28/2018
Reliance on ‘YouTube Medicine’ May Be Dangerous for Those Concerned About Prostate Cancer
Original Press Release Issued by: NYU Langone Health NOVEMBER 27, 2018 (9:30AM) The most popular YouTube videos on prostate cancer often offer misleading or biased medical information that poses potential health risks to patients, an analysis of the social media platform shows. Led by researchers at NYU School of Medicine and NYU... Read More
10/08/2018
Baylor research team awarded $6.3 million NCI grant to develop tools to better understand disparities in prostate, breast cancers
Original Press Release Issued by: Baylor College of Medicine HOUSTON – (Oct. 3, 2018) – As part of the Beau Biden Cancer Moonshot initiative, the National Cancer Institute has awarded $6.3 million dollars to Dr. Nicholas Mitsiades and a multidisciplinary, collaborative team at Baylor College of Medicine to establish a... Read More
10/02/2018
Clovis Oncology Receives Breakthrough Therapy Designation for Rubraca® (rucaparib) for Treatment of BRCA1/2-Mutated Metastatic Castration Resistant Prostate Cancer (mCRPC)
Breakthrough Therapy designation (BTD) granted to Rubraca based on initial data from ongoingTRITON2 Phase 2 study in advanced prostate cancer The data set from the TRITON2 study which supported BTD will be presented at the 2018 ESMO Congress later this month in Munich BOULDER, Colo. (BUSINESS WIRE) -- October... Read More